Sunil Lakhani is a clinical diagnostic and molecular pathologist. He is the Executive Director of Research and Senior Staff Specialist at Pathology Queensland and Head of the Breast Group, University of Queensland Centre for Clinical Research (UQCCR), Brisbane, Australia. His current interests include lobular carcinoma and its variants, triple negative and metaplastic breast cancer and the mechanisms and therapeutic development of brain metastases.
He was Editor of the WHO 4th Ed Tumours of the Breast (2012) and is Editor and Standing member of Board of WHO 5th Ed Tumours of the Breast (2019). He is an elected Board member of Breast Cancer Trials.
He is the recipient of the Distinguished Pathologist Medal, Australasian Division of the International Academy of Pathology and The Distinguished Fellow Award, The Royal College of Pathologists of Australasia. In 2017, he was elected Fellow of the Australian Academy of Health and Medical Sciences.
